CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net income (loss)	$ 1,233	$ (92,262)	$ (111,441)
Adjustments to reconcile net income (loss) to net cash provided by (used by) operating activities:
Stock-based compensation	41,540	39,045	43,387
Depreciation expense and amortization of intangible assets	9,706	10,030	9,473
Lease impairment charges	779	5,462	0
Bad debt expense	1,232	1,760	1,091
Amortization of debt issuance costs	600	589	444
Benefit for deferred income taxes	(349)	(899)	(1,541)
Foreign currency transaction losses (gains), net	(21,732)	16,745	(12,263)
Changes in assets and liabilities:
Accounts receivable	(51,673)	(28,353)	(1,868)
Prepaid expenses and other assets	15,316	16,551	(54,753)
Deferred commissions	(3,195)	(3,144)	(8,043)
Accounts payable and accrued expenses	9,269	(871)	(1,394)
Accrued compensation and related benefits	19,993	(2,947)	(3,157)
Other current and non-current liabilities	(3,489)	(1,478)	(1,134)
Deferred revenue	47,200	49,309	28,668
Operating lease assets and liabilities	(3,556)	(2,659)	2,089
Net cash provided by (used by) operating activities	62,874	6,878	(110,442)
Cash flows from investing activities:
Proceeds from maturities of investments	52,540	20,038	91,670
Purchases of investments	(62,048)	(51,630)	(53,443)
Purchases of property and equipment	(3,318)	(3,798)	(9,637)
Net cash (used by) provided by investing activities	(12,826)	(35,390)	28,590
Cash flows from financing activities:
Proceeds from borrowings	0	50,000	92,000
Payments for debt issuance costs	0	(463)	(276)
Debt repayments	(10,000)	(6,250)	(3,563)
Repurchase of common stock	(20,000)	(50,019)	0
Payments for employee taxes related to the net share settlement of equity awards	(7,396)	(7,987)	(9,748)
Proceeds from exercise of common stock options	1,118	14,461	752
Net cash (used by) provided by financing activities	(36,278)	(258)	79,165
Effect of foreign exchange rate changes on cash and cash equivalents	3,488	(2,029)	1,657
Net increase (decrease) in cash and cash equivalents	17,258	(30,799)	(1,030)
Cash and cash equivalents at beginning of period	118,552	149,351	150,381
Cash and cash equivalents at end of period	135,810	118,552	149,351
Supplemental cash flow information:
Cash paid for interest	19,644	22,574	16,906
Cash paid for income taxes	5,120	3,334	3,999
Supplemental non-cash investing and financing information:
Accrued capital expenditures	$ 87	$ 155	$ 654